Efficacy and Safety of Sorafenib Therapy on Metastatic Renal Cell Carcinoma in Korean Patients: Results from a Retrospective Multicenter Study
about
Sorafenib versus sunitinib as first-line treatment agents in Chinese patients with metastatic renal cell carcinoma: the largest multicenter retrospective analysis of survival and prognostic factors.In-vivo relation between plasma concentration of sorafenib and its safety in Chinese patients with metastatic renal cell carcinoma: a single-center clinical study.
P2860
Efficacy and Safety of Sorafenib Therapy on Metastatic Renal Cell Carcinoma in Korean Patients: Results from a Retrospective Multicenter Study
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Efficacy and Safety of Sorafen ...... etrospective Multicenter Study
@ast
Efficacy and Safety of Sorafen ...... etrospective Multicenter Study
@en
Efficacy and Safety of Sorafen ...... etrospective Multicenter Study
@nl
type
label
Efficacy and Safety of Sorafen ...... etrospective Multicenter Study
@ast
Efficacy and Safety of Sorafen ...... etrospective Multicenter Study
@en
Efficacy and Safety of Sorafen ...... etrospective Multicenter Study
@nl
prefLabel
Efficacy and Safety of Sorafen ...... etrospective Multicenter Study
@ast
Efficacy and Safety of Sorafen ...... etrospective Multicenter Study
@en
Efficacy and Safety of Sorafen ...... etrospective Multicenter Study
@nl
P2093
P2860
P1433
P1476
Efficacy and Safety of Sorafen ...... etrospective Multicenter Study
@en
P2093
Byung-Ho Nam
Cheol Kwak
Choung Soo Kim
Ill Young Seo
Jinsoo Chung
Kanghyon Song
Kwan Joong Joo
Sang Eun Lee
Seong Il Seo
Sung Han Kim
P2860
P304
P356
10.1371/JOURNAL.PONE.0135165
P407
P50
P577
2015-01-01T00:00:00Z